Borzecki Ann M, Glickman Mark E, Kader Boris, Berlowitz Dan R
Center for Health Quality, Outcomes and Economic Research, Bedford Veterans Affairs Hospital, Bedford, Massachusetts 01730, USA.
Am J Hypertens. 2006 May;19(5):520-7. doi: 10.1016/j.amjhyper.2005.10.022.
Despite guidelines recommending similar blood pressure (BP) treatment goals regardless of age, controversy exists regarding treating those > or = 80 years of age. Whether this affects current practice in terms of differences in BP control and number of prescribed antihypertensives by age is unknown.
This was a cross-sectional study of 59,207 outpatients with hypertension treated at 10 Veterans Health Administration sites. Outcome measures were BP control (< 140/90 mm Hg) and number of antihypertensive medications at the patient's last study visit. Uncontrolled BP was also categorized by whether systolic, diastolic, or both were elevated.
Subjects 40 to 49 years and those 50 to 59 years of age had better BP control (adjusted odds ratios 1.35 [95% CI = 1.26 to 1.44] and 1.22 [CI = 1.17 to 1.28] respectively) compared with subjects 60 to 69 years of age; those 70 to 79 years of age and > or = 80 years had worse control (OR = 0.92 for both; respective CIs = 0.88 to 0.96 and 0.86 to 0.99). Antihypertensive medication use increased by successive decade to age 80 years, after which the trend reversed. Adjusted mean number of medications by age were: < 40 years, 2.60; 40 to 49, 2.82; 50 to 59, 2.91; 60 to 69, 3.01; 70 to 79, 3.03; > or = 80 years, 2.90 (P < .05 in pairwise comparisons). The trend of number of medications by age did not vary across hypertension categories, despite systolic hypertension increasing and diastolic hypertension decreasing with age. Subjects < 40 years of age were taking the fewest medications, followed by subjects > or = 80 years and then by those 40 to 49, 50 to 59, 70 to 79, and 60 to 69 years of age.
The oldest hypertension patients, despite worse BP control, are being treated less aggressively with fewer medications than their younger counterparts (those 60 to 79 years of age). Our results suggest that current controversy in treating the oldest hypertensive patients is having an impact on actual practice.
尽管指南推荐无论年龄大小,血压(BP)治疗目标相似,但对于80岁及以上老年人的治疗仍存在争议。目前尚不清楚这在血压控制差异和按年龄开具的抗高血压药物数量方面是否会影响当前的治疗实践。
这是一项对在10个退伍军人健康管理局机构接受治疗的59207例高血压门诊患者进行的横断面研究。观察指标为血压控制情况(<140/90 mmHg)以及患者最后一次研究访视时使用的抗高血压药物数量。血压未得到控制的情况也根据收缩压、舒张压或两者是否升高进行分类。
与60至69岁的受试者相比,40至49岁和50至59岁的受试者血压控制情况更好(调整后的优势比分别为1.35 [95%置信区间 = 1.26至1.44]和1.22 [置信区间 = 1.17至1.28]);70至79岁和80岁及以上的受试者血压控制情况较差(两者的优势比均为0.92;各自的置信区间分别为0.88至0.96和0.86至0.99)。抗高血压药物的使用随年龄每增加一个十年而增加,直至80岁,此后趋势逆转。按年龄调整后的药物平均数量为:<40岁,2.60;40至49岁,2.82;50至59岁,2.91;60至69岁,3.01;70至79岁,3.03;80岁及以上,2.90(两两比较P <.05)。尽管收缩期高血压随年龄增加而增加,舒张期高血压随年龄减少,但按年龄划分的药物数量趋势在不同高血压类别中并无差异。<40岁的受试者服用的药物最少,其次是80岁及以上的受试者,然后是40至49岁、50至59岁、70至79岁和60至69岁的受试者。
年龄最大的高血压患者,尽管血压控制较差,但与年轻患者(60至79岁)相比,接受的治疗力度较小,使用的药物较少。我们的结果表明,目前在治疗年龄最大的高血压患者方面的争议正在对实际治疗实践产生影响。